SYNERTECK INCORPORATED

                       PREFERRED STOCK PURCHASE AGREEMENT

     THIS PREFERRED STOCK PURCHASE  AGREEMENT  (this  "Agreement") is made as of
the 8th day of April, 2005 by and among  SYNERTECK  INCORPORATED,  a  Delaware
corporation (the "Company"), and DAVID ROSS, an individual (the "Investor").

     WHEREAS,  the Company  and the  Investor  desires to acquire  shares of the
Company's Series A Preferred Stock (as such terms are defined below).

     NOW,  THEREFORE,  in  consideration  of the  premises  and  of  the  mutual
agreements,  covenants,  representations  and warranties  contained herein,  the
parties, intending to be legally bound, agree as follows:

1. PURCHASE AND SALE.

     1.1 Sale of Series A Preferred  Stock.  Subject to the terms and conditions
of this  Agreement,  at the Closing  the  Investor  agrees to  purchase  and the
Company agrees to sell and issue Investor 50,000 shares of the Company's  Series
A Preferred Stock,  par value $0.001 per share ("Series A Preferred  Stock") for
$.50 per share, Twenty-Five Thousand Dollars ($25,000.00).

     1.2 Series A Preferred Stock. The Company shall not be able to undertake or
consummate any of the following actions without the prior written consent of the
Investor which may be withheld in the Investor's sole discretion:

          (i)  Filing  of an S-8  registration  statement  with  the  Securities
and Exchange Commission; or

          (ii) Any stock  dividend,  stock  split  (whether  a forward  split or
reverse split), recapitalization, or share capital consolidation.

     1.3  Certificate  of  Designation.  The Company shall file a certificate of
designations  with the state of  Delaware  setting  forth the rights  enumerated
herein.

     1.4 Conversion. The Investor with written notice to the Company may convert
his Series A  Preferred  Stock into  Common  Stock of the  Company  ("Conversion
Shares")on a 1-for-1 basis at any time.  The Company may convert the  Investor's
Series A Preferred Stock into Conversion Shares on a 1-for-1 basis following the
expiration of the three-year  period  commencing on the date of this  Agreement,
with  written  notice  to the  Investor.  Upon the  conversion  of the  Series A
Preferred  Stock as provided  above,  the Investor shall  surrender the Series A
Preferred Stock certificate to the Company's  principal office, duly endorsed or
accompanied  by a written  instrument of transfer duly executed by the Investor.
Concurrently  with the surrender of the Series A Preferred Stock aforesaid,  the
Company shall issue and deliver to the Investor a stock certificate representing
the Conversion Shares.

     1.5 Delivery. The Series A Preferred Stock to be delivered pursuant to this
Agreement,  when so delivered,  will have been duly and validly  authorized  and
issued by the  Company and will be fully paid and  non-assessable.  Furthermore,
upon  conversion  of the Series A Preferred  Stock into  Conversion  Shares,  as
detailed in section 1.4 above, the Conversion Shares issued to the Investor will
be duly and validly  authorized and issued by the Company and will be fully paid
and non-assessable.


                                       1





     1.6 Closing.  The  purchase and sale of the Series A Preferred  Stock shall
take
place at the offices of the Company or at such time and place as the Company and
Investor shall mutually agree (which time and place are designated as the
"Closing"). At the Closing, the Company shall deliver to the Investor a
certificate representing the shares of Series A Preferred Stock that such
Investor is purchasing.

2. REPRESENTATIONS AND WARRANTIES. The Company hereby represents and warrants to
the Investor that:

     2.1  Organization;   Good  Standing;   Qualification.   The  Company  is  a
corporation duly organized, validly existing and in good standing under the laws
of the Delaware.

     2.2  Authorization.  All corporate  action on the part of the Company,  its
officers, directors and stockholders necessary for the authorization,  execution
and  delivery of this  Agreement,  the  performance  of all  obligations  of the
Company hereunder and the authorization, issuance (or reservation for issuance),
sale and  delivery of the Series A Preferred  Stock or  Conversion  Shares being
sold  hereunder  has been taken or will be taken prior to the Closing,  and this
Agreement  constitutes  valid and legally  binding  obligations  of the Company,
enforceable in accordance with their  respective  terms except (a) as limited by
applicable bankruptcy, insolvency, reorganization,  moratorium and other laws of
general application  affecting  enforcement of creditors' rights generally,  and
(b) as limited by laws  relating to the  availability  of specific  performance,
injunctive relief or other equitable remedies.

     2.3 Valid  Issuance of  Securities.  The Series A  Preferred  Stock that is
being purchased by the Investor  hereunder,  when issued,  sold and delivered in
accordance  with the terms of this  Agreement  for the  consideration  expressed
herein, will be duly and validly issued, fully paid and nonassessable,  and will
be free and clear of all pledges,  liens,  encumbrances  and  restrictions.  The
Series A Preferred  Stock,  including  the  Conversion  Shares has been duly and
validly reserved for issuance and, upon issuance in accordance with the terms of
this Agreement,  will be duly and validly issued,  fully paid and nonassessable,
and will be free and clear of all pledges, liens,  encumbrances and restrictions
on transfer other than  restrictions  on transfer under this Agreement and under
applicable securities laws.

3.  REPRESENTATIONS  AND WARRANTIES OF THE INVESTOR.  Investor hereby represents
and warrants to the Company, that:

     3.1 Authorization. Investor has full power and authority to enter into this
Agreement, and this Agreement constitutes a valid and legally binding obligation
of such  Investor,  enforceable  in  accordance  with its  terms,  except (a) as
limited by applicable  bankruptcy,  insolvency,  reorganization,  moratorium and
other laws of general  application  affecting  enforcement of creditors'  rights
generally,  and (b) as limited by laws relating to the  availability of specific
performance, injunctive relief or other equitable remedies.

     3.2 Investment  Experience.  Such Investor is experienced in evaluating and
investing in securities of  early-stage  companies and  acknowledges  that he is
able to fend for himself, can bear the economic risk of its investment,  and has
such  knowledge  and  experience  in financial  and business  matters that he is
capable of  evaluating  the merits and risks of the  investment  in the Series A
Preferred Stock.

     3.4  Restricted  Securities.  Such  Investor  understands  that neither the
Series A Preferred Stock nor the Conversion Shares may not be sold,  transferred
or otherwise disposed of without  registration under applicable  securities laws
or an exemption therefrom,  and that in the absence of an effective registration
statement  covering the Series A Preferred  Stock (or  Conversion  Shares as the
case  may be) or an  available  exemption  from  registration  under  applicable
securities  laws  must be held  indefinitely.  Upon  conversion  from  Series  A
Preferred Stock into Conversion Shares,


                                       2





the Investor may only sell, transfer or dispose of the Conversion Stock pursuant
to Rule 144 of the Securities Act of 1933, if applicable.

4. CONDITIONS OF THE INVESTOR'S OBLIGATIONS AT CLOSING. The obligations of
the  Investor  under  subparagraph  1.1 of this  Agreement  are  subject to the
fulfillment on or before Closing of each of the following conditions. The waiver
of such  obligations  shall not be  effective  against any Investor who does not
consent in writing thereto.

     4.1 Representations  and Warranties.  The representations and warranties of
the Company  contained in Section 2 shall be true and correct in all respects on
and as of Closing.

     4.2  Performance.  The Company  shall have  performed and complied with all
obligations  and conditions  contained in this Agreement that are required to be
performed or complied with by it on or before Closing.

5. CONDITIONS OF THE COMPANY'S OBLIGATIONS AT CLOSING. The obligations of the
Company to the Investor under this Agreement are subject to the fulfillment on
or before Closing of each of the following conditions by the Investor:

     5.1 Representations  and Warranties.  The representations and warranties of
the Investor contained in Section 3 shall be true and correct in all respects on
and as of Closing.

     5.2  Performance.  The Investors shall have performed and complied with all
obligations  and conditions  contained in this Agreement that are required to be
performed or complied with by them on or before Closing.

6. MISCELLANEOUS.

     6.1 Entire Agreement.  This Agreement and the documents  referred to herein
constitute the entire  agreement  among the parties and no party shall be liable
or bound to any other party in any manner by any warranties,  representations or
covenants except as specifically set forth herein or therein.

     6.2   Survival   of   Warranties;    Indemnification.    The    warranties,
representations  and covenants of the Company and each Investor  contained in or
made pursuant to this Agreement shall survive the execution and delivery of this
Agreement and the Closing.

     6.3 Legends.  To the extent applicable,  each certificate or other document
evidencing  any of Series A Preferred  Stock or any  Conversion  Shares shall be
endorsed  with the legend set forth below,  and such  Investor  covenants  that,
except to the extent such restrictions are waived by the Company,  such Investor
shall not  transfer  the  shares  represented  by any such  certificate  without
complying with the restrictions on transfer described in the legends endorsed on
such certificate:

     "THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED OR
QUALIFIED UNDER APPLICABLE  FEDERAL OR STATE SECURITIES LAWS, AND MAY BE OFFERED
AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF
SUCH LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL OR OTHER  EVIDENCE
SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION  UNDER SUCH LAWS
IS NOT REQUIRED."

     6.4 Successors and Assigns.  Except as otherwise provided herein, the terms
and  conditions of this  Agreement  shall inure to the benefit of and be binding
upon the respective  successors and assigns


                                       3





of the parties (including permitted transferees of Series A Preferred Stock sold
hereunder). Nothing in this Agreement, express or implied, is intended to confer
upon any party other than the parties hereto or their respective  successors and
assigns any rights,  remedies,  obligations or liabilities under or by reason of
this Agreement, except as expressly provided in this Agreement.

     6.5 Governing Law; Venue. This Agreement shall be governed by and construed
under  the  laws  of the  State  of  Utah,  without  regard  to its  body of law
controlling  conflicts of law.  Venue with respect to any action  regarding this
Agreement or the transactions  contemplated hereby shall be proper solely in the
state and federal courts located within Salt Lake County, Utah.

     6.6   Counterparts.   This  Agreement  may  be  executed  in  two  or  more
counterparts,  each of  which  shall be  deemed  an  original,  but all of which
together shall constitute one and the same instrument.

     6.7 Titles and  Subtitles.  The titles and subtitles used in this Agreement
are used for  convenience  only and are not to be  considered  in  construing or
interpreting this Agreement.

     6.8 Notices. Unless otherwise provided, any notice and other communications
required  or  permitted  under this  Agreement  shall be in writing and shall be
mailed  by  United  States  first-class  mail,  postage  prepaid,  or  delivered
personally by hand or by a nationally  recognized courier addressed to the party
to be notified at the address  indicated  for such party below or on Schedule A,
or at such other  address as such party may  designate  by ten (10) days advance
written notice to the other parties  hereto.  All such notices and other written
communications  shall be effective on the earlier of: (i) five (5) days from the
date of mailing or actual receipt by the party to be notified.

     6.9  Attorneys'  Fees.  If any action at law or in equity is  necessary  to
enforce or interpret the terms of the Agreement,  the prevailing  party shall be
entitled to reasonable  attorneys' fees, costs and  disbursements in addition to
any other relief to which such party may be entitled.

     6.10 Amendments and Waivers.  Any term of this Agreement may be amended and
the  observance  of any term of this  Agreement  may be waived  with the written
consent of the Company and the Investor.

     6.11 Severability.  If one or more provisions of this Agreement are held to
be  unenforceable  under  applicable  law, such provision shall be excluded from
this Agreement and the balance of the Agreement  shall be interpreted as if such
provision  were so excluded  and shall be  enforceable  in  accordance  with its
terms.

      [remainder of page intentionally left blank; signature page follows]









                                       4





     IN WITNESS WHEREOF, the parties have executed this Preferred Stock Purchase
Agreement as of the date first above written.

COMPANY:

SYNERTECK INCORPORATED


By: /s/ Clayton Barlow
    _______________________________
Name: Clayton Barlow
      _____________________________
Title: President
       ____________________________

Address: 11585 South State Street, Suite 102
         Draper, Utah 84020
         Attn: President
         Phone Number:801-816-2505
         Fax Number:801-816-2599


INVESTOR:
/s/ David Ross
__________________________________

DAVID ROSS

Address: 1890 East 10980 South
         Sandy, Utah 84092
         Attn: David Ross
         Phone Number:801-571-4626
         Fax Number:
















                                       5




                                    Exhibit A

                              Disclosure Schedules

                                 [see attached]





























                                       6